121 results
Page 2 of 7
S-8 POS
2v665ez w5fc
20 Sep 22
Registration of securities for employees (post-effective amendment)
9:18am
S-8 POS
6s2vg26p05b3n4e8q
20 Sep 22
Registration of securities for employees (post-effective amendment)
9:16am
POS AM
8yil0t zxwnnp
20 Sep 22
Prospectus update (post-effective amendment)
9:15am
POS AM
0r85c3 z7e
20 Sep 22
Prospectus update (post-effective amendment)
9:14am
POS AM
6mv4 e4ckzciowhdl7uw
20 Sep 22
Prospectus update (post-effective amendment)
9:14am
POS AM
n8y29rnu0 znrowt
20 Sep 22
Prospectus update (post-effective amendment)
9:13am
POS AM
zosowg n2fk
20 Sep 22
Prospectus update (post-effective amendment)
9:10am
8-K
EX-10.1
k3xisx
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-10.1
710c3n
19 Jul 22
InMed Announces Appointment of Chief Operating Officer
7:43pm
8-K
EX-10.1
fcvkmm
15 Jul 22
Departure of Directors or Certain Officers
8:28pm
424B3
p5l5bjj
6 Jul 22
Prospectus supplement
2:43pm
8-K
EX-10.2
s8vsd1m
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.1
axc9obupwc4r
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
424B5
ktlnqufd t0pqs8
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
y1buy4ss0rt
25 Apr 22
Prospectus supplement
5:02pm
8-K
EX-10.1
zjvloj10
7 Apr 22
Entry into a Material Definitive Agreement
4:47pm